Status:
UNKNOWN
Cardiac Injury in COVID-19: a Pathology Study
Lead Sponsor:
A.O. Ospedale Papa Giovanni XXIII
Collaborating Sponsors:
CVPath Institute Inc. Renu Virmani, Aloke Finn
A.O. Ospedale Papa Giovanni XXIII, Anatomia Patologica, Dr Andrea Gianatti, co-PI
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The primary goal of the study is to conduct the first systematic cardiac autopsy study in 60 patients dying from COVID-19 to understand the pathology and pathogenesis of cardiac injury in patients wit...
Detailed Description
Since Dec 2019, coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has resulted in considerable morbidity and mortality throughout the world....
Eligibility Criteria
Inclusion
- Hospitalized patients at Papa Giovanni XXIII Hospital, Bergamo, forefront of the COVIT-19 pandemic in Italy
- COVID-19 positive patients who died with/without a picture of cardiac injury
Exclusion
- COVID-19 negative patients who died
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04367792
Start Date
April 23 2020
End Date
March 1 2021
Last Update
August 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST Ospedale Papa Giovanni XXIII
Bergamo, Italy, 24127